Associate Director, Biologics CMC Drug Product

Cullinan Therapeutics (NASDAQ: CGEM) is a clinical-stage biotech company developing potential first- or best-in-class, high-impact molecules in autoimmune diseases and cancer, where exceptional scientific expertise, strategic risk-taking, and rigorous decision-making unite to improve peoples’ lives.

We believe in a future where those living with autoimmune diseases and cancer spend less time managing their conditions and more time on what matters most. With deep expertise in immune modulation, Cullinan is where speed meets strategy to move profound innovations forward.

But movement isn’t just about speed — it’s about meaning. Our work is fueled by curiosity, determination, and compassion. We work side by side with our partners across the life science ecosystem to channel our collective potential into improving the lives of people living with autoimmune diseases and cancer.

The Associate Director, Biologics CMC Drug Product Development position is a key role responsible for conducting drug product development and manufacturing from preclinical through early and late (pivotal) clinical development to commercialization for a pipeline of novel biologics products.  The Associate Director, Biologics CMC Drug Product will be a member of the CMC team (within Technical Operations), reporting to the Executive Director, Biologics CMC Drug Product.  This role provides the opportunity to contribute to Cullinan’s biologics drug product capabilities and involves close collaboration with various teams including process development, analytical sciences, supply chain, quality, regulatory, research, clinical, finance, and legal.  The execution of all development, manufacturing, and testing for Cullinan Therapeutics is entirely via a network of external providers.